Maternal opioids downregulate adiponectin receptor signaling and alter growth in offspring: pilot study
< 0.01). Maternal OUD may be associated with aberrant growth and excess adiposity in offspring through its effect on adiponectin signaling, predisposing these neonates to cardiometabolic risks.
Authors
- Tomoko Kaneko-Tarui (ORCID: https://orcid.org/0000-0001-5463-1551)
- Taysir Mahmoud (ORCID: https://orcid.org/0000-0001-9225-6115)
- May J. Chow
- Elizabeth Yen (ORCID: https://orcid.org/0000-0002-5916-3299)
- Jill L. Maron (ORCID: https://orcid.org/0000-0002-1071-8468)
- Angie Mae Rodday (ORCID: https://orcid.org/0000-0002-8671-3401)
- P S Reddy
- Kiran Singh
- Francesca Carasi-Schwartz
- Emily Brew
- Mario Cordova
- Perrie O’Tierney-Ginn
- Jonathan M. Davis
Institutions
- Tufts University (US)
- Women & Infants Hospital of Rhode Island (US)
- Watching Over Mothers & Babies (US)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3389/fped.2026.1755488
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tufts Medical Center
- National Center for Advancing Translational Sciences